Vimarsana
Biggest News Aggregation in the World

Used Alone News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Used Alone. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Used Alone Today - Breaking & Trending Today

What is the efficacy of curcumin as a photosensitizer, prophylactic and therapeutic agent against SARS-CoV-2? - Vimarsana News

What is the efficacy of curcumin as a photosensitizer, prophylactic and therapeutic agent against SARS-CoV-2?

Published: September 30, 2022

In a new study, researchers investigated the efficacy of curcumin as a blue light photosensitizing agent for photodynamic therapy (PDT), as a prophylactic agent, and as a therapeutic agent against SARS-CoV-2.

Source: news-medical.net
Related Topics:
Madeleine Steinbach ShutterstockUsed AloneImage CreditCoronavirus Disease Covid 19Ars Cov 2Anti InflammatoryCovid 19N VitroPhotodynamic TherapyEvere Acute RespiratoryEvere Acute Respiratory Syndrome
Phexxi® Prevented 99% of Pregnancies Per Act of Intercourse in a Post Hoc Analysis of Phase 3 AMPOWER Clinical Trial Data - Vimarsana News

Phexxi® Prevented 99% of Pregnancies Per Act of Intercourse in a Post Hoc Analysis of Phase 3 AMPOWER Clinical Trial Data

Published: June 16, 2022

/PRNewswire/ -- Evofem Biosciences, Inc., (Nasdaq: EVFM) today announced results of a post hoc analysis of the registrational Phase 3 AMPOWER trial...

Source: prnewswire.com
Related Topics:
United StatesAmy RaskopfEvofem BioscienceJack HirschfieldSaundra PelletierEvofem BiosciencesAmerican College Of ObstetriciansSecurities ExchangeEvofem Biosciences IncPrnewswire Evofem Biosciences IncTypical UseChief Executive OfficerSexual MedicineAmerican CollegeProduct InformationSecurities Exchange ActPrivate Securities Litigation Reform ActAnnual ReportUsed AloneCochrane DatabaseSystematic Reviews